The first report, where tumor development was driven by the ErbB2 oncogene [39], showed both faster onset of tumor genesis, higher primary tumor numbers, larger volume of primary tumors, as well as a higher number of metastases and larger volume of metastases in lipocalin-2 expressing mice. This evidence concerns the gene ERBB2 and neoplasm.